Table 2.
Demographics and vaccine received for participants included in immunogenicity analysis. Values are numbers (percentages) unless stated otherwise
| Characteristic | Age band | |||
|---|---|---|---|---|
| 11-13 years (n=407) | 14-16 years (n=410) | 17-20 years (n=170) | All ages (n=987) | |
| Male | 235 (58) | 224 (55) | 78 (46) | 537 (54) |
| Mean (SD) age (years) | 12.8 (0.63) | 15.4 (0.85) | 18.0 (0.85) | 14.8 (2.02) |
| Mean (SD) age at immunisation (years) | 8.1 (0.64) | 10.4 (0.77) | 12.7 (0.84) | 9.9 (1.81) |
| Mean (SD) time since immunisation (years) | 4.7 (0.22) | 5.0 (0.30) | 5.3 (0.23) | 4.9 (0.34) |
| Vaccine received | ||||
| NeisVac-C | 65 (16) | 31 (8) | 0 | 96 (10) |
| Menjugate | 275 (68) | 297 (72) | 136 (80) | 708 (71) |
| Meningitec | 41 (10) | 32 (8) | 22 (13) | 95 (10) |
| Unknown | 26 (6) | 50 (12) | 12 (7) | 88 (9) |